Yunchao Wang - Concepedia

Author

Yunchao Wang

Peking Union Medical College Hospital

Also Known As

Wang, Yunchao, Yun-chao Wang, Yunchao Wang, Yun‐Chao Wang

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Southwest Hospital Army Medical University Zhengzhou University

About

Yunchao Wang is an author at Peking Union Medical College Hospital specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	349
2	Engineering	2	2	76
3	Natural Sciences	2	2	74
4	Public Health	2	2	37
5	Biochemistry	2	2	48

Yunchao Wang

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers Jinzhu Mao, Dongxu Wang, Junyu Long, Journal for ImmunoTherapy of Cancer	2021	249
RETRACTED: Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR-874-3p and inhibiting PLK1 expression Wenjie Huang, Yunchao Wang, Songsong Liu, Cancer Letters Tumor BiologyPancreatic CancerPathologyPlk1 ExpressionSmall Rna	2018	133
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma Nan Zhang, Yang Xu, Mingjian Piao, Biomarker Research	2024	72
Microarray expression profile analysis of circular RNAs in pancreatic cancer Shixiang Guo, Xuejun Xu, Yongsheng Ouyang, Molecular Medicine Reports Tumor BiologyEngineeringPancreatic CancerCircular RnasCircrna Microarray	2018	62
Expression induction of P450 genes by imidacloprid in Nilaparvata lugens: A genome-scale analysis Jianhua Zhang, Yixi Zhang, Yunchao Wang, Pesticide Biochemistry and Physiology BiologyFunctional GenomicsNilaparvata LugensNatural SciencesGenetics	2015	59
Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer Jian Li, Yunchao Wang, Jiayun Ge, Cellular Physiology and Biochemistry	2018	57
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients Xu Yang, Bowen Chen, Yanyu Wang, Hepatology International	2023	54
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy Xiaobo Yang, Haifeng Xu, Bangyou Zuo, HepatoBiliary Surgery and Nutrition	2021	50
Transcriptional downregulation of miR‐127‐3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5 Jiaxing Fan, Wenzhi Du, Hui Zhang, FEBS Letters Transcriptional DownregulationPathologyCancer BiologyTumor BiologyTranscriptional Regulation	2019	42
Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer Chengpei Zhu, Jingnan Xue, Yunchao Wang, Frontiers in Immunology	2023	37

Page 1